FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

CRISIL

1,898.05
-21.8 (-1.14%)
Updated 03:29 14/05 IST

CRISIL Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for CRISIL
Disclaimer
0% Bullish
0% Bearish

CRISIL Buy or Sell - Brokerage Reports

No. of reports in last year
1
No. of analysts
1
Average Consensus Forecast
1490
Consensus Potential
-28.85%
See CRISIL Share Price Targets >>

CRISIL Ratings

Long term CRISIL rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live CRISIL message board: Is CRISIL buy or sell? Should I buy CRISIL shares? Why are CRISIL shares falling? Should I invest in CRISIL stock?

  1. Home
  2. CRISIL Forum

CRISIL Share Price Discussion

N
Reputation: 13,722 • May 10 1:06 AM
Crisil flags off downside risks to its FY'22 growth forecast after the second wave
CRISILs base GDP growth forecast for fiscal 2022 at stands at 11% but risks are firmly tilted downwards. It has projected two scenarios. One of a moderate downside where GDP growth drops to 9.8%, assuming second wave peaks by May-end. The other of severe downside where GDP growth drops to 8.2%, assuming second wave peaks by June-end.
The Economic Times
Like
Reply
N
Reputation: 13,722 • May 10 10:51 AM
Crisil upgrades Indel Money's credit rating
The rating of Indel Money on the short-term scale has also been upgraded to ‘A3 Plus from ‘A3 minus.
The Economic Times
Like
Reply

Type
Buy
Instrument
CRISIL
Entry Price
₹1,900
Price@Trade
₹1,900
Target Price
₹1,907
Stop Price
₹1,895
Valid Till
May 10, 2021 3:20 AM
Margin
₹1,900 approx for 1 Qty
Status
Exited
Exit Price
₹1,900.15
Net P&L
+₹0.15 (+0.01%)
Like
Reply (1)
swap_vert
Trade
See all replies
Kennedy @kennedy-BkmNUsevO
May 10 7:33 AM

Update
Exited
Exit Price
₹1,900.15
Net P&L
+₹0.15 (+0.01%)
N
Reputation: 13,722 • May 7 8:56 AM
RBI's Rs 50K crore liquidity facility can augment hospital bed capacity by 20%: Crisil
"Increased availability of funds at low cost will incentivise hospitals to augment beds, oxygen storage, ICUs and critical medical equipment," its chief ratings officer Subodh Rai said.
The Economic Times
Like
Reply

CRISIL - chart - 2981298
Free Trade🔥🔥🔥🔥🔥
Crisil Ltd:
Monthly chart
Buy 1870
SL 1740
Target 2070,2250,2370
Always follow Risk management and psychological stability when taking trade.
Being Disciplined is the only thing that pays off in the securities market in long run.
This is only for education ...
Read more...
Like
Reply
N
Reputation: 13,722 • May 6 2:11 AM
Majority of SMEs qualify for restructuring says Crisil
Last fiscal, a third of these SMEs had cushioned their liquidity by availing of the RBI mandated six month moratorium on bank loans. Later a bounce back in demand helped in recovery which had limited the number of companies that had opted for restructuring under the first restructuring window that ended on March 31 2021.
The Economic Times
Like
Reply
N
Reputation: 13,722 • May 6 11:41 AM
Crisil says half of its rated mid-sized cos eligible for loan recast under new guidelines
Companies with relatively weaker credit profiles, and part of low-resilience sectors are expected to benefit more from the scheme, Crisil said, specifying that mid-sized companies are those having aggregate exposures of less than Rs 500 crore.
The Economic Times
Like
Reply

Type
Buy
Instrument
CRISIL
Entry Price
₹1,919
Price@Trade
₹1,918.9
Target Price
₹1,950
Stop Price
₹1,900
Valid Till
May 11, 2021 3:20 AM
Margin
₹997,880 approx for 520 Qty
Status
Exited
Exit Price
₹1,905.85
Net P&L
-₹6,838 (-0.69%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
May 4 6:14 AM

Update
Trade Entered
Entry Price
₹1,919
Sumit @sumit-rygCQ35Ld
May 4 6:54 AM

Update
Exited
Exit Price
₹1,905.85
Net P&L
-₹6,838 (-0.69%)
N
Reputation: 13,722 • May 3 6:56 AM
Covid curbs start hitting economy; Crisil says rapid vaccination must to avoid deeper pain
Indias crushing second wave of Covid-19 continues to make new peaks every passing day, as daily cases near the 4 lakh mark.
The Economic Times
Like
Reply
N
Reputation: 13,722 • Apr 30 10:56 AM
Second wave restrictions: Crisil says multiplexes to be on losses; may recover only in FY23
The sector, arguably one of the worst impacted in the pandemic, can look at a recovery only in the next financial year, the report by domestic credit rating agency Crisil said.
The Economic Times
Like
Reply
N
Reputation: 13,722 • Apr 28 2:26 AM
IndiGrid InvIT hits public bond sale, gets double subscriptions
A large Mumbai-based infrastructure conglomerate and a private life insurance company attached to a “salt-to-steel” group bid to own those papers with yield-hungry wealthy investors taking the lead, sources told ET.
The Economic Times
Like
Reply
N
Reputation: 13,722 • Apr 28 5:51 AM
Scrappage offtake to skid on limited incentive and poor cost economics for trucks
To be sure, the scrappage policy is much required as older vehicles are 10-12 times more polluting than newer ones. As things stand, India is home to six of the top 10 polluting cities globally, and is among the top five polluting countries.
The Economic Times
Like
Reply
N
Reputation: 13,722 • Apr 27 7:21 AM
India's 4G user base may grow to 820 million in FY22 as telcos expand coverage: Crisil
“With the recent spectrum acquisition, telcos are well-positioned to handle any surge in data traffic, leading to increased aggression by the players to gain market share,” the ratings agency said in a research report.
The Economic Times
Like
Reply
N
Reputation: 13,722 • Apr 26 8:31 AM
Buy Crisil, target price Rs 2261: Edelweiss Securities
Edelweiss Securities has buy call on Crisil with a target price of Rs 2261. The current market price of Crisil is Rs 1889.95.
The Economic Times
Like
Reply
N
Reputation: 13,722 • Apr 22 4:51 AM
Buy Crisil, target price Rs 2200: Centrum Broking
Crisil Ltd., incorporated in the year 1987, is a Mid Cap company (having a market cap of Rs 13333.41 Crore) operating in Financial Services sector.
The Economic Times
Like
Reply
N
Reputation: 13,722 • Apr 21 9:21 AM
Restriction in supply of industrial oxygen to impact revenues of small & mid-sized manufacturers: Crisil
Demand for medical oxygen is estimated to have rocketed five-fold in the second week of April versus pre-pandemic levels as Covid-19 infections took off.
The Economic Times
Like
Reply
N
Reputation: 13,722 • Apr 19 1:31 AM
SGX Nifty down 130 points; what changed for market while you were sleeping
Asian markets were trading mixed in Monday's trade. Japans Nikkei was flat at 29,659.36, Hong Kongs Hang Seng fell 0.17 per cent; Koreas Kospi was up 0.28 per cent while Chinas Shanghai Composite index edged 0.13 per cent higher.
The Economic Times
Like
Reply
N
Reputation: 13,722 • Apr 13 1:41 AM
SGX Nifty down 5 points; here's what changed for market while you were sleeping
Asian markets were trading largely higher in Tuesdays trade despite overnight fall in US stocks. Japans Nikkei jumped 1.03 per cent, Hong Kongs Hang Seng climbed 1.2 per cent; Koreas Kospi advanced 0.8 per cent while Chinas Shanghai Composite index edged 0.04 per cent lower.
The Economic Times
Like
Reply
N
Reputation: 13,722 • Apr 12 10:21 AM
Fall in gold prices may not significantly impact NBFCs asset quality: Report
However, banks that were aggressively disbursing gold loans during the last fiscal may see some impact on their asset quality, Crisil Ratings said in a report.
The Economic Times
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • CRISIL - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization11,672.63
    Enterprise Value11,621.63
    Price to Earnings41.99
    Price to Book Value14.43
    Return on Capital Employed0.34
    Return on Equity0.34
    Face Value1
    Dividend Yield0.19
  • CRISIL - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    16-Apr-20Rudra Shares & Stocks BrokersBuy1,490
    23-Apr-19CentrumAdd1,600
    20-Feb-19EdelweissReduce1,331
    18-Dec-18CentrumBuy1,980
    22-Feb-18Axis DirectBuy2,241
    CRISIL Brokerage Price Target
  • CRISIL Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    May 141939.319551881.751900.6
    May 1219101946.91896.51919.85
    May 11189819121887.451906.9
    May 101853.219081853.151897.5
    May 71871.351884.051846.351853.2
  • CRISIL Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹1,879.23
    30 Day Moving Average₹1,859.34
    50 Day Moving Average₹1,884.92
    100 Day Moving Average₹1,905.48
    200 Day Moving Average₹1,869.57
  • CRISIL - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDDec-18Dec-17 % Change
    Revenue1,1821,177.380
    Operating Profit322319.390.01
    Profit Before Tax381346.050.1
    Net Income278237.260.17
  • CRISIL - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDDec-18Dec-17 % Change
    Shareholder's Funds809811.7-0
    Total Liabilities322316.720.02
    Total Assets1,1311,128.420
  • CRISIL - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDDec-18Dec-17 % Change
    Cash from Operating Activity279272.20.02
    Cash from Investing Activity-79-68.210.16
    Cash from Financing Activity-195-186.580.05
    Net Cash Flow617.41-0.66
  • CRISIL - Ratios

    keyboard_arrow_down
    CONSOLIDATEDDec-18Dec-17
    Return on Assets0.250.21
    Return on Equity0.340.29
    Return on Capital Employed0.340.43
  • CRISIL - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.24
    3 Year CAGR Growth in Operating Profit0.07
    3 Year CAGR Growth in EBIDTA0.13
    3 Year CAGR Growth in Net Income0.25
    3 Yr CAGR Growth - Diluted EPS0.24
  • CRISIL - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.5
    5 Year CAGR Growth in Operating Profit0.19
    5 Year CAGR Growth in EBIDTA0.27
    5 Year CAGR Growth in Net Income-0.01
    3 Yr CAGR Growth - Diluted EPS-0.03
  • CRISIL - Recent News

    keyboard_arrow_down
    NewsBot
    May 10 1:06 AM
    Crisil flags off downside risks to its FY'22 growth forecast after the second wave
    The Economic Times
    NewsBot
    May 10 10:51 AM
    Crisil upgrades Indel Money's credit rating
    The Economic Times
    NewsBot
    May 7 8:56 AM
    RBI's Rs 50K crore liquidity facility can augment hospital bed capacity by 20%: Crisil
    The Economic Times
    NewsBot
    May 6 2:11 AM
    Majority of SMEs qualify for restructuring says Crisil
    The Economic Times
    NewsBot
    May 6 11:41 AM
    Crisil says half of its rated mid-sized cos eligible for loan recast under new guidelines
    The Economic Times
    NewsBot
    May 3 6:56 AM
    Covid curbs start hitting economy; Crisil says rapid vaccination must to avoid deeper pain
    The Economic Times
    NewsBot
    Apr 30 10:56 AM
    Second wave restrictions: Crisil says multiplexes to be on losses; may recover only in FY23
    The Economic Times
    NewsBot
    Apr 28 2:26 AM
    IndiGrid InvIT hits public bond sale, gets double subscriptions
    The Economic Times
    NewsBot
    Apr 28 5:51 AM
    Scrappage offtake to skid on limited incentive and poor cost economics for trucks
    The Economic Times
    NewsBot
    Apr 26 8:31 AM
    Buy Crisil, target price Rs 2261: Edelweiss Securities
    The Economic Times
  • CRISIL - Related Communities

    keyboard_arrow_down
    Sun TV Network Ltd. NSE: SUNTV | BSE:...
    PVR Ltd. NSE: PVR | BSE: 532689 | ISI...
    Just Dial Ltd. NSE: JUSTDIAL | BSE: 5...
    Adani Enterprises Ltd. NSE: ADANIENT ...
    Dish TV India Ltd. NSE: DISHTV | BSE:...
    Central Depository Services (India) L...
    INOX Leisure Ltd. NSE: INOXLEISUR | B...
    Reliance Industrial Infrastructure Lt...
    Engineers India Ltd. NSE: ENGINERSIN ...
    TV18 Broadcast Ltd. NSE: TV18BRDCST |...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020